PAREXEL International to Participate in Lazard Capital Medical Technology / Life Science Tools Day and Deutsche Bank MedTools Investor Summit |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
PAREXEL International Corp.
200 West St.
Waltham, MA, 02451-1163
USA
Press release date: November 29, 2010
BOSTON, Nov. 29, 2010 - PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be participating in the Lazard Capital Medical Technology / Life Science Tools Day in Denver, CO on Thursday, December 2, 2010.
PAREXEL will also be participating in the Deutsche Bank MedTools Investor Summit in Boston, MA on Tuesday, December 7, 2010.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has approximately 10,170 employees. For more information about PAREXEL International visit www.PAREXEL.com.
SOURCE PAREXEL International Corporation
CONTACT:
Jill Baker,
Corporate Vice President,
PAREXEL International,
+1-781-434-4118,
Jill.Baker@PAREXEL.com
Web Site: http://www.parexel.com
|
|
|
|
|
|
